Table_3_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_4_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_2_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_1_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_8_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

LSK cells expanded by IL-27 and SCF are multipotent myeloid Progenitors. by Jun-ichi Furusawa (554613)

“…Data are shown as mean ± SEM (n = 2–4) and are representative of two to three independent experiments. …”

Twsg1 null mice were resistant to podocyte injury. by Sachiko Yamada (527282)

“…While Twsg1^+/+:NEP25 mice injected with immunotoxin (Tswg1+/+LMB2+, n = 30) showed decreased levels of serum albumin and increased levels of total cholesterol compared to the controls (Tswg1+/+LMB2-, n = 13), these changes in serum parameters were significantly attenuated in Twsg1^LacZ/LacZ:NEP25 mice (Tswg1−/−LMB2+, n = 24). …”

Data_Sheet_1_Dietary Nitrate Supplementation Does Not Alter Exercise Efficiency at High Altitude – Further Results From the Xtreme Alps Study.docx by Philip J. Hennis (12158271)

“…Using a double-blind protocol, participants were randomized to consume a beetroot/fruit juice beverage (three doses per day) with high levels of nitrate (∼0.18 mmol/kg/day) or a nitrate-depleted placebo (∼11.5 μmoles/kg/day) control drink, from 3 days prior to the exercise trials until completion. …”

Desflurane impairs outcome of organotypic hippocampus slices in an in vitro model of traumatic brain injury by Mark Coburn (1376460)

“…<div><b>Abstract</b></div>Decreasing mortality and disability after traumatic brain injury is a significant medical challenge. …”

Image_1_Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models.tif by Peter S. N. van Rossum (5241293)

“…The Christie model predictors for grade ≥3 lymphopenia included age, baseline lymphocyte count, radiotherapy duration, chemotherapy, mean heart and lung doses, and thoracic vertebrae V20Gy. …”

Table_1_Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models.docx by Peter S. N. van Rossum (5241293)

“…The Christie model predictors for grade ≥3 lymphopenia included age, baseline lymphocyte count, radiotherapy duration, chemotherapy, mean heart and lung doses, and thoracic vertebrae V20Gy. …”

Differences in the total investment under the “climate-adapted” and “climate-neutral” allocations. by Takuya Iwamura (236242)

“…“Cold” colors (pale blue and dark blue) represent the ecoregions with decreased investment. The result for the A1fi IPCC emission scenario is displayed. …”

Table_4_Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study.DOCX by Enrique Gutiérrez-González (10281707)

“…</p>Results<p>Crude prevalences of obesity and excess weight were higher in men (obesity: 19.3% vs. 18.0%; excess weight: 63.7% vs. 48.4%), while severe obesity was more prevalent in women (4.5% vs. 5.3%). These prevalences increased with age and disability, and decreased with education, census tract income and municipality size. …”

Image_1_Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study.PDF by Enrique Gutiérrez-González (10281707)

“…</p>Results<p>Crude prevalences of obesity and excess weight were higher in men (obesity: 19.3% vs. 18.0%; excess weight: 63.7% vs. 48.4%), while severe obesity was more prevalent in women (4.5% vs. 5.3%). These prevalences increased with age and disability, and decreased with education, census tract income and municipality size. …”

Table 4_Global, regional, and national epidemiology of Intracerebral Hemorrhage among women of childbearing age (1990–2021): incidence, mortality, DALYs, and risk factor analysis.x... by Yuan Li (67017)

“…DALYs lost totaled 5,040,596 years (95% UI: 4,432,534–5,654,102), with a DALY rate of 249.334 (95% UI: 222.411–277.622) per 100,000 people. …”

Table 2_Global, regional, and national epidemiology of Intracerebral Hemorrhage among women of childbearing age (1990–2021): incidence, mortality, DALYs, and risk factor analysis.x... by Yuan Li (67017)

“…DALYs lost totaled 5,040,596 years (95% UI: 4,432,534–5,654,102), with a DALY rate of 249.334 (95% UI: 222.411–277.622) per 100,000 people. …”

Image_3_Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study.PDF by Enrique Gutiérrez-González (10281707)

“…</p>Results<p>Crude prevalences of obesity and excess weight were higher in men (obesity: 19.3% vs. 18.0%; excess weight: 63.7% vs. 48.4%), while severe obesity was more prevalent in women (4.5% vs. 5.3%). These prevalences increased with age and disability, and decreased with education, census tract income and municipality size. …”

Image_2_Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study.PDF by Enrique Gutiérrez-González (10281707)

“…</p>Results<p>Crude prevalences of obesity and excess weight were higher in men (obesity: 19.3% vs. 18.0%; excess weight: 63.7% vs. 48.4%), while severe obesity was more prevalent in women (4.5% vs. 5.3%). These prevalences increased with age and disability, and decreased with education, census tract income and municipality size. …”

Table_2_Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study.DOCX by Enrique Gutiérrez-González (10281707)

“…</p>Results<p>Crude prevalences of obesity and excess weight were higher in men (obesity: 19.3% vs. 18.0%; excess weight: 63.7% vs. 48.4%), while severe obesity was more prevalent in women (4.5% vs. 5.3%). These prevalences increased with age and disability, and decreased with education, census tract income and municipality size. …”

Table_1_Socio-geographical disparities of obesity and excess weight in adults in Spain: insights from the ENE-COVID study.DOCX by Enrique Gutiérrez-González (10281707)

“…</p>Results<p>Crude prevalences of obesity and excess weight were higher in men (obesity: 19.3% vs. 18.0%; excess weight: 63.7% vs. 48.4%), while severe obesity was more prevalent in women (4.5% vs. 5.3%). These prevalences increased with age and disability, and decreased with education, census tract income and municipality size. …”